HORIBA: Acquired US reagent manufacturer: MedTest Dx ・ Pointe Scientific
HORIBA:
Acquired Medtest Holdings (Michigan), a manufacturer of clinical test reagents.
The purchase price has not been disclosed, but it is estimated to be less than 1 billion yen.
Medtest:
Handles biochemical reagents used for analysis of blood and urine.
In addition to developing and producing biochemical reagents
Development of inspection methods for biochemical reagents,
It also has the function of responding to regulatory approvals.
HORIBA’s biochemistry business:
Horiba is the biochemical business of sales of the medical business in 2023 prospect, plans to raise 60 billion yen of 19-year ratio of 5 premium.
The acquisition is part of this strategy.
Blood analysis solution:
In Horiba’s medical business, blood analysis solutions are the mainstay.
A blood cell counter that measures the number of red blood cells, etc.
Combined with biochemical reagents,
Accelerate comprehensive blood analysis solutions.
New switch
HORIBA acquires MedTest Dx and Pointe Scientific to expand laboratory Chemistry offerings
02/03/2021
HORIBA, Ltd.
HORIBA Instruments (Headquarters in Irvine, California, USA)
announced today that it has acquired MedTest Holdings, Inc. (Headquarters in Canton, MI, USA, composed of MedTest Dx, Inc., Pointe Scientific, Inc., Clinitox Diagnostix, Inc., and Medical Laboratory Solutions, Inc.).
The acquisition
will combine the complementary innovative technology offerings of the HORIBA Medical segment with MedTest Dx technology, Clinitox, and Pointe Scientific’s R&D and manufacturing capabilities,
with particular expertise in FDA 510K and CLIA clearances, to address the multidisciplinary requirements of IVD※1 testing customers.
This acquisition
provides HORIBA Medical the opportunity to address the IVD market’s multidisciplinary requirements along with the complementary innovative technology of Pointe Scientific and MedTest’s high quality Chemistry solutions.
HORIBA Medical
will continue offering innovative technology solutions through its Yumizen※2 brand and current distribution channels,
said HORIBA Medical segment leader Dr. Jai Hakhu, Chairman and CEO of HORIBA Instruments Incorporated and President of HORIBA ABX SAS in France.
HORIBA